Mylan gets FDA nod for generic cholesterol drug

05/19/2013 | RTT News

The FDA has granted Mylan Pharmaceuticals approval for its fenofibrate tablets in 48 mg and 145 mg strengths to reduce levels of low-density lipoprotein cholesterol, total cholesterol, triglycerides and apolipoprotein B, and boost high-density lipoprotein cholesterol. The drug is a generic version of Abbvie's Tricor.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR